Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Dec 19, 2017 at 11:05 AM EST

Portola Pharma Wins With FDA Approval

Portola Pharmaceuticals shares saw a handy gain on Tuesday after the company announced that it received a key approval from…

Chris Lange | Dec 18, 2017 at 1:35 PM EST

Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal

Valeant Pharmaceuticals shares made a spectacular crash over the course of 2015 to 2017, and it looks like they may…

Jon C. Ogg | Dec 18, 2017 at 12:30 PM EST

Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback

Pfizer has just raised its payout by about 6% and more than doubled what it already had on its buyback…

Chris Lange | Dec 18, 2017 at 8:35 AM EST

FDA Accepts Teva Pharma’s BLA for Migraine Drug

Teva Pharmaceutical Industries kicked off the week by announced an FDA for its treatment for migraines.

Lee Jackson | Dec 18, 2017 at 7:45 AM EST

Analyst Sees 3 Red-Hot Medical Technology Stocks as Huge 2018 Buys

These three red-hot companies continue to dominate their specific spheres of the medical technology world, and their stocks have had…

Trey Thoelcke | Dec 15, 2017 at 7:20 AM EST

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Shares of Pfizer appeared to be headed for a new high after the company announced that the FDA had approved…

Douglas A. McIntyre | Dec 15, 2017 at 6:25 AM EST

Teva Pharmaceuticals: Happy Holidays, You’re Fired

Another company has decided that the best time to fire a large number of people is just before the holidays.

Chris Lange | Dec 13, 2017 at 1:40 PM EST

Investors Can’t Seem to Make Up Their Minds on Teva’s Restructuring

Teva Pharmaceutical Industries shares turned south on Wednesday after the company said that it would be announcing its restructuring plan…

Chris Lange | Dec 13, 2017 at 11:30 AM EST

Bluebird Bio Stumbles Over Secondary Offering

Bluebird Bio saw its shares dip on Wednesday after the firm announced the pricing of a secondary offering of more…

Chris Lange | Dec 13, 2017 at 11:05 AM EST

Why Cellectis Is Winning Big With Its Pfizer Partnership

Cellectis saw its shares make a handy gain early on Wednesday after the firm announced preliminary data from its two…

Chris Lange | Dec 12, 2017 at 12:00 PM EST

Why Proteostasis Shares Are Exploding

Proteostasis Therapeutics shares absolutely exploded in Tuesday’s session, more than doubling after the firm reported positive study results.

Chris Lange | Dec 12, 2017 at 10:40 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Dec 12, 2017 at 10:10 AM EST

Major Biotechs See Rising Tide in Short Interest

The November 30 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Dec 11, 2017 at 1:15 PM EST

Will Consumers Trust Generic Viagra?

A generic version of Viagra is coming to America, but will existing customers be willing to switch over to a…

Chris Lange | Dec 11, 2017 at 10:25 AM EST

Blueprint Medicines Wins Big in Early-Stage Trial

Blueprint Medicines watched its shares make a solid gain on Monday morning after the firm announced results for its ongoing…

1 … 147 148 149 150 151 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Portola Pharma Wins With FDA Approval

Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal

Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback

FDA Accepts Teva Pharma’s BLA for Migraine Drug

Analyst Sees 3 Red-Hot Medical Technology Stocks as Huge 2018 Buys

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Teva Pharmaceuticals: Happy Holidays, You’re Fired

Investors Can’t Seem to Make Up Their Minds on Teva’s Restructuring

Bluebird Bio Stumbles Over Secondary Offering

Why Cellectis Is Winning Big With Its Pfizer Partnership

Why Proteostasis Shares Are Exploding

Short Sellers Can’t Make Up Their Minds on Major Pharma

Major Biotechs See Rising Tide in Short Interest

Will Consumers Trust Generic Viagra?

Blueprint Medicines Wins Big in Early-Stage Trial

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

Health and Healthcare Articles

All Health and Healthcare Articles

Portola Pharma Wins With FDA Approval

Valeant Pharmaceuticals Well on the Road to Recovery After Bausch + Lomb Distribution Deal

Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback

FDA Accepts Teva Pharma’s BLA for Migraine Drug

Analyst Sees 3 Red-Hot Medical Technology Stocks as Huge 2018 Buys

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Teva Pharmaceuticals: Happy Holidays, You’re Fired

Investors Can’t Seem to Make Up Their Minds on Teva’s Restructuring

Bluebird Bio Stumbles Over Secondary Offering

Why Cellectis Is Winning Big With Its Pfizer Partnership

Why Proteostasis Shares Are Exploding

Short Sellers Can’t Make Up Their Minds on Major Pharma

Major Biotechs See Rising Tide in Short Interest

Will Consumers Trust Generic Viagra?

Blueprint Medicines Wins Big in Early-Stage Trial

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how